While it is unclear how best to combine other factors with NT‐proBNP in the setting of screening, for risk prediction in diabetes, NT‐proBNP alone can adequately risk stratify patients with diabetes for future cardiovascular risk, with other variables adding little to the risk prediction over the measurement of NT‐proBNP alone.33, 34. This evidence concerns the gene NPPB and diabetes mellitus.